Baxter International Inc (BAX)

BAX on New York Consolidated

69.28USD
23 Oct 2014
Price Change (% chg)

$0.91 (+1.33%)
Prev Close
$68.37
Open
$68.98
Day's High
$69.34
Day's Low
$68.95
Volume
592,682
Avg. Vol
2,404,113
52-wk High
$77.31
52-wk Low
$64.78

BAX

Chart for BAX

About

Baxter International Inc. (Baxter) is a global, diversified healthcare company. Baxter, through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions.... (more)

Overall

Beta: 0.72
Market Cap (Mil.): $37,034.21
Shares Outstanding (Mil.): 541.67
Dividend: 0.52
Yield (%): 3.04

Financials

  BAX Industry Sector
P/E (TTM): 21.40 31.84 33.65
EPS (TTM): 3.20 -- --
ROI: -- 8.70 17.48
ROE: -- 12.03 18.31
Search Stocks

Medical products push Baxter profit above estimate

- Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.

16 Oct 2014

UPDATE 1-Medical products push Baxter profit above estimate

Oct 16 - Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales in its medical products business continued to grow.

16 Oct 2014

Medical products push Baxter profit above estimate

Oct 16 - Medical device and drug maker Baxter International Inc reported a higher-than-expected quarterly profit, as sales at its medical products business continued to grow.

16 Oct 2014

Baxter plans to open R&D center in Massachusetts for Baxalta spinoff

- Baxter International Inc on Monday said it would form a research and development center in Cambridge, Massachusetts, for the biopharmaceutical business it expects to spin off as a separate company in mid-2015.

29 Sep 2014

Baxter plans to open R&D center in Mass. for Baxalta spinoff

Sept 29 - Baxter International Inc on Monday said it would form a research and development center in Cambridge, Massachusetts, for the biopharmaceutical business it expects to spin off as a separate company in mid-2015.

29 Sep 2014

Kamada extends emphysema drug deal with Baxter through 2017

JERUSALEM - Israeli drugmaker Kamada said on Monday it extended an agreement with Baxter International to supply a drug to treat emphysema through 2017.

29 Sep 2014

Kamada extends emphysema drug deal with Baxter through 2017

JERUSALEM, Sept 29 - Israeli drugmaker Kamada said on Monday it extended an agreement with Baxter International to supply a drug to treat emphysema through 2017.

29 Sep 2014

Baxter to market Merrimack's cancer drug outside U.S.

- Merrimack Pharmaceuticals Inc said it would partner with Baxter International Inc to develop and market Merrimack's pancreatic cancer drug outside the United States.

24 Sep 2014

UPDATE 2-Baxter to market Merrimack's cancer drug outside U.S.

* Merrimack to get $100 million upfront payment from Baxter

24 Sep 2014

US STOCKS-Bed, Bath & Beyond, Merrimack Pharma surge in premarket

NEW YORK, Sept 24 - Merrimack Pharmaceuticals shares were surging in premarket trade, up 24.5 percent to $8.95 after the company said it reached a deal to develop and market Merrimack's pancreatic cancer drug outside the U.S. with Baxter International.

24 Sep 2014

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $102.73 +1.51
Pfizer Inc. (PFE.N) $28.84 +0.55
Roche Holding Ltd. (ROG.VX) CHF279.30 +1.00
Abbott Laboratories (ABT.N) $42.50 +0.91
Boston Scientific Corporation (BSX.N) $12.59 +0.27
Wyeth Limited (WLED.NS) Rs1,053.70 +27.10
Hospira, Inc. (HSP.N) $51.31 +1.23

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00
Provider: S&P Capital IQ – STARS Reports
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks